| Literature DB >> 27265755 |
Tao Zhang1, Jin-Guang Si1,2, Qiu-Bo Zhang1, Gang Ding1, Zhong-Mei Zou1.
Abstract
Eight highly oxygenated germacranolides (1-8) including four new ones (2-5) were isolated from the whole plant of Carpesium divaricatum. The planar structures and relative configurations of the new compounds were determined by NMR experiment and HRESIMS data. The absolute configuration of 1 was established by circular dichroism (CD) method and X-ray diffraction, and the stereochemistry of the new compounds 2-5 were determined by similar CD spectra with 1. Compound 2 is the first hydroperoxyl germacrane from the genus Carpesium. The (13)C NMR data of 1, NMR data of 6-7, and their absolute configurations were reported for the first time. Two new compounds (2 and 4) and two known compounds (6 and 8) exhibited potent cytotoxicity against human cervical cancer (HeLa) cells, superior to that of the positive control doxorubicin.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27265755 PMCID: PMC4893730 DOI: 10.1038/srep27237
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1chemical structures of compounds 1–8.
Figure 2CD spectra of compounds 1–5.
Figure 3X-ray ORTEP drawing of 1.
1H NMR spectral data for compounds 1–7 (J in Hz within parentheses).
| No. | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| 1 | 1.68 o | 1.69 o, 1.24 m | 1.69 o, 1.24 m | 1.72 m, 1.24 m | 2.37 m, 2.18 m | 1.69 o, 1.24 m | 1.71 o, 1.23 m |
| 2 | 1.54 m, 1.44 m | 1.57 m, 1.46 m | 1.56 m, 1.45 m | 1.58 m, 1.45 m | 5.98 m | 1.55 m, 1.45 m | 1.54 m, 1.45 m |
| 3 | 1.68 o, 1.68 o | 1.69 o, 1.69 o | 1.69 o, 1.69 o | 1.69 o, 1.69 o | 5.63 br d (17.0) | 1.69 o, 1.69 o | 1.71 o, 1.71 o |
| 5 | 4.67 d (6.0) | 4.75 d (6.5) | 4.70 d (6.5) | 4.69 d (6.0) | 4.68 d (8.5) | 4.68 d (6.0) | 4.69 d (6.0) |
| 6 | 4.58 dd (6.5, 2.0) | 4.63 dd (6.5, 2.0) | 4.62 dd (6.5, 1.5) | 4.62 dd (6.0, 2.0) | 4.40 br d (8.5) | 4.59 dd (6.5, 2.0) | 4.60 dd (6.0, 1.5) |
| 7 | 3.79 dd (11.5, 2.0) | 3.87 dd (11.5, 2.0) | 3.87 dd (11.5, 1.5) | 3.88 dd (11.5, 2.0) | 3.64 dd (10.0, 1.5) | 3.78 dd (11.5, 2.0) | 3.81 dd (11.5, 1.5) |
| 8 | 4.76 d (11.5) | 4.92 d (11.0) | 4.91 d (11.5) | 4.92 d (11.0) | 4.74 d (10.5) | 4.84 d (11.5) | 4.80 d (11.5) |
| 10 | 3.24 m | 3.27 m | 3.27 m | 3.29 m | 3.43 m | 3.24 m | 3.25 m |
| 13a | 6.30 d (1.5) | 6.27 d (2.0) | 6.27 d (2.0) | 6.27 d (1.5) | 6.27 d (1.5) | 6.29 d (2.0) | 6.32 d (2.0) |
| 13b | 6.03 d (1.5) | 5.96 d (2.0) | 5.97 d (2.0) | 5.98 d (1.5) | 5.88 d (1.5) | 6.03 d (2.0) | 6.05 d (2.0) |
| 14 | 1.00 d (6.5) | 1.01 d (7.0) | 1.01 d (7.0) | 1.00 d (6.5) | 1.07 d (6.5) | 1.03 d (6.5) | 1.04 d (7.0) |
| 15 | 1.13 s | 1.19 s | 1.15 s | 1.15 s | 1.24 s | 1.14 s | 1.15 s |
| 2′ | 2.69 o | 2.68 m | 2.67 m | 2.67 m | 2.68 m | ||
| 3′ | 1.18 d (7.0) | 1.46 s | 1.45 s | 1.19 d (7.0) | 1.20 d (7.0) | 1.19 d (7.0) | 1.19 d (7.0) |
| 4′ | 1.17 d (7.0) | 1.42 s | 1.41 s | 1.17 d (7.0) | 1.17 d (7.0) | 1.17 d (7.0) | 1.17 d (7.0) |
| 2″ | 2.69 o | 2.36 o, 2.36 o | 2.53 m | ||||
| 3″ | 1.22 d (7.0) | 6.30 q (6.5) | 6.31 q (6.5) | 6.31 dq (3.0, 1.0), 5.83 dq (3.0,1.0) | 6.28 q (6.5) | 2.09 m | 1.71 m, 1.54 o |
| 4″ | 1.15 d (7.0) | 2.00 br s | 2.00 br s | 1.99 br s | 1.95 br s | 0.98 d (6.5) | 1.19 d (7.0) |
| 5″ | 1.98 dq (6.5, 1.5) | 1.99 dq (6.5, 1.5) | 1.97 dq (6.5, 1.5) | 0.97 d (7.0) | 0.94 t (9.0) |
aMeasured at 500 MHz in CD3OD.
bOverlapped with other signals.
13C NMR spectral data for compounds 1–7.
| No. | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| 1 | 22.8 | 22.8 | 22.8 | 22.9 | 36.5 | 22.9 | 22.7 |
| 2 | 37.8 | 37.6 | 37.5 | 37.7 | 131.0 | 37.7 | 37.8 |
| 3 | 34.5 | 34.5 | 34.5 | 34.4 | 130.9 | 34.5 | 34.7 |
| 4 | 73.8 | 73.9 | 74.0 | 73.8 | 75.5 | 73.8 | 73.8 |
| 5 | 78.6 | 79.4 | 79.3 | 78.7 | 78.5 | 78.6 | 78.4 |
| 6 | 73.2 | 73.3 | 73.7 | 73.1 | 73.4 | 73.2 | 73.3 |
| 7 | 46.2 | 46.3 | 46.2 | 46.3 | 46.0 | 46.2 | 46.2 |
| 8 | 80.0 | 79.8 | 79.8 | 80.3 | 79.9 | 80.0 | 79.8 |
| 9 | 213.5 | 213.5 | 213.5 | 213.3 | 210.7 | 213.5 | 213.5 |
| 10 | 42.4 | 42.7 | 42.7 | 42.7 | 44.4 | 42.5 | 42.3 |
| 11 | 134.7 | 134.7 | 134.7 | 134.9 | 134.9 | 134.8 | 134.6 |
| 12 | 170.7 | 170.6 | 170.6 | 170.7 | 170.8 | 170.7 | 170.7 |
| 13 | 127.6 | 127.4 | 127.4 | 127.4 | 127.4 | 127.6 | 127.7 |
| 14 | 20.9 | 20.9 | 20.9 | 20.8 | 18.6 | 21.0 | 21.0 |
| 15 | 24.8 | 24.8 | 24.8 | 24.8 | 25.9 | 24.8 | 24.9 |
| 1′ | 178.7 | 175.0 | 177.2 | 178.7 | 178.6 | 178.7 | 178.7 |
| 2′ | 34.9 | 84.8 | 73.2 | 34.9 | 35.1 | 34.9 | 34.9 |
| 3′ | 19.4 | 23.1 | 27.2 | 19.2 | 19.3 | 19.2 | 19.2 |
| 4′ | 19.2 | 22.7 | 27.7 | 19.2 | 19.4 | 19.2 | 19.2 |
| 1″ | 177.0 | 167.1 | 167.1 | 166.9 | 167.4 | 173.0 | 176.6 |
| 2″ | 35.1 | 127.6 | 127.6 | 136.8 | 127.6 | 43.6 | 42.2 |
| 3″ | 19.2 | 143.1 | 143.1 | 128.2 | 142.8 | 26.5 | 27.7 |
| 4″ | 19.1 | 20.7 | 20.7 | 18.4 | 20.6 | 22.7 | 16.8 |
| 5″ | 16.1 | 16.1 | 16.1 | 22.7 | 12.0 |
aMeasured at 125MHz in CD3OD.
Figure 4Key 1H-1H COSY and HMBC correlations of compounds 2–5.
Cytotoxicity of Compounds 1, 2, 4 and 6–8.
| compounds | IC50(μM) | |||
|---|---|---|---|---|
| HeLa | Hep G2 | MGC-803 | A549 | |
| 4.36 ± 0.12 | 6.41 ± 0.23 | 4.63 ± 0.25 | 21.7 ± 1.41 | |
| 0.83 ± 0.09 | 8.40 ± 0.84 | 4.48 ± 1.01 | 8.93 ± 1.73 | |
| 1.18 ± 0.14 | 14.20 ± 0.21 | 2.93 ± 0.57 | 27.8 ± 2.34 | |
| 0.57 ± 0.06 | 18.10 ± 0.72 | 3.49 ± 0.40 | 20.7 ± 0.84 | |
| 3.58 ± 0.21 | 9.55 ± 0.27 | 4.63 ± 0.59 | 22.7 ± 0.94 | |
| 1.70 ± 0.24 | 8.28 ± 0.64 | 2.70 ± 0.65 | 16.3 ± 1.41 | |
| doxorubicin | 2.21 ± 0.18 | 5.40 ± 0.80 | 0.74 ± 0.05 | 4.18 ± 0.52 |
Values were mean ± SD. Doxorubicin, positive control. Cell lines: HeLa: cervical cancer, Hep G2: hepatocellular cancer, MGC-803: stomach cancer, and A549: lung cancer.